Researchers seek to improve upon risk stratification for patients with aggressive thyroid cancer.
A multicenter cohort study of patients with obesity suggests a decreased risk of developing new obesity-related cancers in patients with a history of bariatric surgery.
A new study indicates that the combined approaches can be performed without mortality and with acceptable morbidity.
Newly published data from Cleveland Clinic’s 21-year experience treating ATCs provide reasons for optimism in the current era of targeted and immune therapies.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
The Director of Head & Neck Endocrine Surgery at Cleveland Clinic’s Head & Neck Institute discusses how the department is contributing to the future of thyroid cancer care.
Treatment decisions for indeterminate nodules can be challenging, as evidenced by a new study that finds a high rate of intra or post-operative conversion from unilateral thyroid lobectomy to complete thyroidectomy. Endocrine surgeon Allan Siperstein, MD, explains the implications of his research.
A multidisciplinary approach in preoperative planning and postoperative management is necessary to improve outcomes for patients with more advanced thyroid cancer.
Team in the Cleveland Clinic Endocrinology & Metabolism Institute conducts a study to look at the clinical usefulness of chest X-rays before thyroidectomy.
This study of a family with Cowden Syndrome and thyroid cancer revealed the role of USF3 and potential therapeutic breakthroughs.
A Cleveland Clinic expert on thyroid tumors weighs in on the increasing number of thyroid cancer diagnoses. He offers recommendations on when to order diagnostic tests and highlights the need for better testing.